| CASE REPORT |
|
| Year : 2012 | Volume
: 16
| Issue : 3 | Page : 450-452 |
|
|
Osteonecrosis of jaw associated with bisphosphonate use
Ashu Rastogi1, Vidya Rattan2, Sanjay Kumar Bhadada1
1 Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 Department of Oral Health Sciences, Post Graduate Institute of Medical Education and Research, Chandigarh, India
Correspondence Address:
Sanjay Kumar Bhadada
Department of Endocrinology, PGIMER, Chandigarh - 160 012
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2230-8210.95711
|
|
|
Bisphosphonates are associated with osteonecrosis of the jaw (ONJ) that is defined as an area of exposed, nonvital bone in the maxilla or mandible persisting over 6-8 weeks. We describe a case of 55-year-old female who developed ONJ after tooth extraction and had been receiving oral ibandronate for osteoporosis. Diagnosis of ONJ was confirmed on CT scan. The patient was managed conservatively as she denied teriparatide therapy because of cost constraints. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
